001     140482
005     20240321220822.0
024 7 _ |a 10.15252/emmm.201809665
|2 doi
024 7 _ |a pmid:30617153
|2 pmid
024 7 _ |a pmc:PMC6365929
|2 pmc
024 7 _ |a 1715-4684
|2 ISSN
024 7 _ |a 1757-4676
|2 ISSN
024 7 _ |a 1757-4684
|2 ISSN
024 7 _ |a altmetric:53595424
|2 altmetric
037 _ _ |a DZNE-2020-06804
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Reichenbach, Nicole
|0 P:(DE-2719)2811281
|b 0
|e First author
245 _ _ |a Inhibition of Stat3-mediated astrogliosis ameliorates pathology in an Alzheimer's disease model.
260 _ _ |a Heidelberg
|c 2019
|b EMBO Press
264 _ 1 |3 online
|2 Crossref
|b EMBO
|c 2019-01-07
264 _ 1 |3 print
|2 Crossref
|b EMBO
|c 2019-02-01
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1708432762_6808
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Reactive astrogliosis is a hallmark of Alzheimer's disease (AD), but its role for disease initiation and progression has remained incompletely understood. We here show that the transcription factor Stat3 (signal transducer and activator of transcription 3), a canonical inducer of astrogliosis, is activated in an AD mouse model and human AD Therefore, using a conditional knockout approach, we deleted Stat3 specifically in astrocytes in the APP/PS1 model of AD We found that Stat3-deficient APP/PS1 mice show decreased β-amyloid levels and plaque burden. Plaque-close microglia displayed a more complex morphology, internalized more β-amyloid, and upregulated amyloid clearance pathways in Stat3-deficient mice. Moreover, astrocyte-specific Stat3-deficient APP/PS1 mice showed decreased pro-inflammatory cytokine activation and lower dystrophic neurite burden, and were largely protected from cerebral network imbalance. Finally, Stat3 deletion in astrocytes also strongly ameliorated spatial learning and memory decline in APP/PS1 mice. Importantly, these protective effects on network dysfunction and cognition were recapitulated in APP/PS1 mice systemically treated with a preclinical Stat3 inhibitor drug. In summary, our data implicate Stat3-mediated astrogliosis as an important therapeutic target in AD.
536 _ _ |a 341 - Molecular Signaling (POF3-341)
|0 G:(DE-HGF)POF3-341
|c POF3-341
|f POF III
|x 0
536 _ _ |a 342 - Disease Mechanisms and Model Systems (POF3-342)
|0 G:(DE-HGF)POF3-342
|c POF3-342
|f POF III
|x 1
536 _ _ |a 344 - Clinical and Health Care Research (POF3-344)
|0 G:(DE-HGF)POF3-344
|c POF3-344
|f POF III
|x 2
542 _ _ |i 2019-01-07
|2 Crossref
|u http://creativecommons.org/licenses/by/4.0/
542 _ _ |i 2019-01-07
|2 Crossref
|u http://doi.wiley.com/10.1002/tdm_license_1.1
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a STAT3 Transcription Factor
|2 NLM Chemicals
650 _ 7 |a STAT3 protein, human
|2 NLM Chemicals
650 _ 7 |a Stat3 protein, mouse
|2 NLM Chemicals
650 _ 2 |a Alzheimer Disease: pathology
|2 MeSH
650 _ 2 |a Animals
|2 MeSH
650 _ 2 |a Astrocytes: pathology
|2 MeSH
650 _ 2 |a Cell Proliferation
|2 MeSH
650 _ 2 |a Disease Models, Animal
|2 MeSH
650 _ 2 |a Gene Knockout Techniques
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Mice
|2 MeSH
650 _ 2 |a Mice, Knockout
|2 MeSH
650 _ 2 |a STAT3 Transcription Factor: analysis
|2 MeSH
650 _ 2 |a STAT3 Transcription Factor: deficiency
|2 MeSH
700 1 _ |a Delekate, Andrea
|0 P:(DE-2719)2810454
|b 1
700 1 _ |a Plescher, Monika
|0 P:(DE-2719)2812070
|b 2
700 1 _ |a Schmitt, Franziska
|0 P:(DE-2719)2812206
|b 3
700 1 _ |a Krauß, Sybille
|0 P:(DE-2719)2421562
|b 4
700 1 _ |a Blank, Nelli
|0 P:(DE-2719)2811722
|b 5
700 1 _ |a Halle, Annett
|0 P:(DE-2719)2812038
|b 6
700 1 _ |a Petzold, Gabor C
|0 P:(DE-2719)2810273
|b 7
|e Last author
773 1 8 |a 10.15252/emmm.201809665
|b : EMBO, 2019-01-07
|n 2
|3 journal-article
|2 Crossref
|t EMBO Molecular Medicine
|v 11
|y 2019
|x 1757-4676
773 _ _ |a 10.15252/emmm.201809665
|g Vol. 11, no. 2
|0 PERI:(DE-600)2485479-7
|n 2
|q 11:2
|p e9665
|t EMBO molecular medicine
|v 11
|y 2019
|x 1757-4676
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/140482/files/DZNE-2020-06804.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/140482/files/DZNE-2020-06804.pdf?subformat=pdfa
856 7 _ |2 Pubmed Central
|u http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365929
909 C O |o oai:pub.dzne.de:140482
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)2811281
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)2810454
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 2
|6 P:(DE-2719)2812070
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 3
|6 P:(DE-2719)2812206
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 4
|6 P:(DE-2719)2421562
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 5
|6 P:(DE-2719)2811722
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 6
|6 P:(DE-2719)2812038
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 7
|6 P:(DE-2719)2810273
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-341
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Molecular Signaling
|x 0
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-342
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Disease Mechanisms and Model Systems
|x 1
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-344
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 2
914 1 _ |y 2019
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-29
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b EMBO MOL MED : 2021
|d 2022-11-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2021-07-19T13:19:31Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2021-07-19T13:19:31Z
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b EMBO MOL MED : 2021
|d 2022-11-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-29
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Blind peer review, Double blind peer review
|d 2021-07-19T13:19:31Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-29
920 1 _ |0 I:(DE-2719)1013020
|k AG Petzold ; AG Petzold
|l Vascular Neurology
|x 0
920 1 _ |0 I:(DE-2719)1013003
|k AG Bano
|l Aging and Neurodegeneration
|x 1
920 1 _ |0 I:(DE-2719)1011006
|k AG Krauß
|l Regulatory RNA-protein interaction in neurodegenerative diseases
|x 2
920 1 _ |0 I:(DE-2719)1013034
|k AG Halle
|l Microglia and Neuroinflammation
|x 3
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1013020
980 _ _ |a I:(DE-2719)1013003
980 _ _ |a I:(DE-2719)1011006
980 _ _ |a I:(DE-2719)1013034
980 1 _ |a FullTexts
999 C 5 |9 -- missing cx lookup --
|a 10.1128/MCB.21.5.1621-1632.2001
|2 Crossref
|o 10.1128/MCB.21.5.1621-1632.2001
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neuron.2008.10.013
|2 Crossref
|o 10.1016/j.neuron.2008.10.013
999 C 5 |9 -- missing cx lookup --
|a 10.1523/JNEUROSCI.3516-14.2015
|2 Crossref
|o 10.1523/JNEUROSCI.3516-14.2015
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neuron.2013.12.034
|2 Crossref
|o 10.1016/j.neuron.2013.12.034
999 C 5 |9 -- missing cx lookup --
|a 10.2967/jnumed.110.087031
|2 Crossref
|o 10.2967/jnumed.110.087031
999 C 5 |9 -- missing cx lookup --
|a 10.1186/s40478-018-0606-1
|2 Crossref
|o 10.1186/s40478-018-0606-1
999 C 5 |9 -- missing cx lookup --
|a 10.1038/ncomms7176
|2 Crossref
|o 10.1038/ncomms7176
999 C 5 |9 -- missing cx lookup --
|a 10.1038/ncomms6422
|2 Crossref
|o 10.1038/ncomms6422
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.yjmcc.2003.10.006
|2 Crossref
|o 10.1016/j.yjmcc.2003.10.006
999 C 5 |9 -- missing cx lookup --
|a 10.3758/BF03193146
|2 Crossref
|o 10.3758/BF03193146
999 C 5 |9 -- missing cx lookup --
|a 10.1021/ml4003138
|2 Crossref
|o 10.1021/ml4003138
999 C 5 |9 -- missing cx lookup --
|a 10.1016/S1474-4422(15)70016-5
|2 Crossref
|o 10.1016/S1474-4422(15)70016-5
999 C 5 |9 -- missing cx lookup --
|a 10.1523/JNEUROSCI.1709-08.2008
|2 Crossref
|o 10.1523/JNEUROSCI.1709-08.2008
999 C 5 |9 -- missing cx lookup --
|a 10.1111/jnc.13490
|2 Crossref
|o 10.1111/jnc.13490
999 C 5 |9 -- missing cx lookup --
|a 10.1093/hmg/ddh019
|2 Crossref
|o 10.1093/hmg/ddh019
999 C 5 |9 -- missing cx lookup --
|a 10.1002/(SICI)1098-1136(200005)30:3<253::AID-GLIA5>3.0.CO;2-O
|2 Crossref
|o 10.1002/(SICI)1098-1136(200005)30:3<253::AID-GLIA5>3.0.CO;2-O
999 C 5 |9 -- missing cx lookup --
|a 10.1073/pnas.1300378110
|2 Crossref
|o 10.1073/pnas.1300378110
999 C 5 |9 -- missing cx lookup --
|a 10.1038/nature21029
|2 Crossref
|o 10.1038/nature21029
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neuron.2018.10.031
|2 Crossref
|o 10.1016/j.neuron.2018.10.031
999 C 5 |9 -- missing cx lookup --
|a 10.1038/nm1425
|2 Crossref
|o 10.1038/nm1425
999 C 5 |9 -- missing cx lookup --
|a 10.1038/nn.2535
|2 Crossref
|o 10.1038/nn.2535
999 C 5 |9 -- missing cx lookup --
|a 10.1038/nrn.2016.141
|2 Crossref
|o 10.1038/nrn.2016.141
999 C 5 |9 -- missing cx lookup --
|a 10.1182/blood-2006-02-003012
|2 Crossref
|o 10.1182/blood-2006-02-003012
999 C 5 |9 -- missing cx lookup --
|a 10.1152/physrev.00041.2013
|2 Crossref
|o 10.1152/physrev.00041.2013
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s00401-015-1513-1
|2 Crossref
|o 10.1007/s00401-015-1513-1
999 C 5 |9 -- missing cx lookup --
|a 10.1073/pnas.1117218109
|2 Crossref
|o 10.1073/pnas.1117218109
999 C 5 |9 -- missing cx lookup --
|a 10.1172/JCI89354
|2 Crossref
|o 10.1172/JCI89354
999 C 5 |9 -- missing cx lookup --
|a 10.1084/jem.20171487
|2 Crossref
|o 10.1084/jem.20171487
999 C 5 |9 -- missing cx lookup --
|a 10.1038/s41586-018-0119-x
|2 Crossref
|o 10.1038/s41586-018-0119-x
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neuron.2012.03.026
|2 Crossref
|o 10.1016/j.neuron.2012.03.026
999 C 5 |y 2014
|2 Crossref
|o Schafer DP 2014
999 C 5 |9 -- missing cx lookup --
|a 10.1126/scitranslmed.aaf6295
|2 Crossref
|o 10.1126/scitranslmed.aaf6295
999 C 5 |9 -- missing cx lookup --
|a 10.1038/nn.3691
|2 Crossref
|o 10.1038/nn.3691
999 C 5 |9 -- missing cx lookup --
|a 10.1038/s41467-017-01283-z
|2 Crossref
|o 10.1038/s41467-017-01283-z
999 C 5 |9 -- missing cx lookup --
|a 10.1016/S1474-4422(10)70325-2
|2 Crossref
|o 10.1016/S1474-4422(10)70325-2
999 C 5 |9 -- missing cx lookup --
|a 10.1038/ni.3691
|2 Crossref
|o 10.1038/ni.3691
999 C 5 |9 -- missing cx lookup --
|a 10.1038/nprot.2006.116
|2 Crossref
|o 10.1038/nprot.2006.116
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s12264-018-0262-2
|2 Crossref
|o 10.1007/s12264-018-0262-2
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neuroscience.2006.06.034
|2 Crossref
|o 10.1016/j.neuroscience.2006.06.034
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s11064-011-0576-1
|2 Crossref
|o 10.1007/s11064-011-0576-1
999 C 5 |9 -- missing cx lookup --
|a 10.1038/s41591-018-0051-5
|2 Crossref
|o 10.1038/s41591-018-0051-5
999 C 5 |9 -- missing cx lookup --
|a 10.1523/JNEUROSCI.6221-11.2012
|2 Crossref
|o 10.1523/JNEUROSCI.6221-11.2012


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21